Reference health

Discovery and Pharmacological Characterization of Novel Quinazoline-Based PI3K Delta-Selective Inhibitors

https://doi.org/10.1021/acsmedchemlett.6b00119
CiteStamped reference-health badge
33/33 checkable references clean · checked 2026-07-22

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

1 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 33 checked references that resolve
resolves10.1126/science.296.5573.1655
The Phosphoinositide 3-Kinase Pathway
resolves10.1016/j.bbalip.2014.12.006
PI3K signalling in inflammation
resolves10.1073/pnas.0700373104
Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers
resolves10.1016/j.bbapap.2007.10.003
Targeting phosphoinositide 3-kinase—Moving towards therapy
resolves10.1517/14728222.12.2.223
Class IA phosphatidylinositol 3-kinase: from their biologic implication in human cancers to drug discovery
resolves10.1124/pr.110.004051
Inhibition of PI3K Signaling Spurs New Therapeutic Opportunities in Inflammatory/Autoimmune Diseases and Hematological Malignancies
resolves10.1038/nri2036
PI3Kδ and PI3Kγ: partners in crime in inflammation in rheumatoid arthritis and beyond?
resolves10.1016/j.coph.2015.05.017
PI3K inhibitors in inflammation, autoimmunity and cancer
resolves10.1126/science.287.5455.1049
Central Role for G Protein-Coupled Phosphoinositide 3-Kinase γ in Inflammation
resolves10.1126/science.287.5455.1046
Roles of PLC-β2 and -β3 and PI3Kγ in Chemoattractant-Mediated Signal Transduction
resolves10.1016/j.cell.2004.07.017
PI3Kγ Modulates the Cardiac Response to Chronic Pressure Overload by Distinct Kinase-Dependent and -Independent Effects
resolves10.1084/jem.20020805
A Crucial Role for the p110δ Subunit of Phosphatidylinositol 3-Kinase in B Cell Development and Activation
resolves10.1128/MCB.22.24.8580-8591.2002
Essential, Nonredundant Role for the Phosphoinositide 3-Kinase p110δ in Signaling by the B-Cell Receptor Complex
resolves10.1126/science.1073560
Impaired B and T Cell Antigen Receptor Signaling in p110δ PI 3-Kinase Mutant Mice
resolves10.4049/jimmunol.170.5.2647
Essential Role of Phosphoinositide 3-Kinase δ in Neutrophil Directional Movement
resolves10.1183/09031936.00106609
Phosphoinositide 3-kinase δ inhibitor suppresses interleukin-17 expression in a murine asthma model
resolves10.3109/08916934.2012.732130
Selective pharmacological inhibition of phosphoinositide 3-kinase p110delta opposes the progression of autoimmune diabetes in non-obese diabetic (NOD) mice
resolves10.1517/13543776.2011.629606
Selective PI3Kδ inhibitors, a review of the patent literature
resolves10.1016/j.bmcl.2015.01.001
Synthesis and SAR study of potent and selective PI3Kδ inhibitors
resolves10.1021/jm501624r
Discovery and in Vivo Evaluation of (<i>S</i>)-<i>N</i>-(1-(7-Fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9<i>H</i>-purin-6-amine (AMG319) and Related PI3Kδ Inhibitors for Inflammation and Autoimmune Disease
resolves10.1021/acs.jmedchem.5b01651
Discovery, Optimization, and in Vivo Evaluation of Benzimidazole Derivatives AM-8508 and AM-9635 as Potent and Selective PI3Kδ Inhibitors
resolves10.1158/1535-7163.MCT-08-0017
Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent <i>in vivo</i> antitumor activity
resolves10.1038/nm1284
Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis
resolves10.1016/S0014-2999(01)01362-0
[3H]Dofetilide binding to HERG transfected membranes: a potential high throughput preclinical screen
resolves10.1021/jm049377w
High-Throughput Lipophilicity Measurement with Immobilized Artificial Membranes
resolves10.1021/jm8008663
Metabolic Soft Spot Identification and Compound Optimization in Early Discovery Phases Using MetaSite and LC-MS/MS Validation
resolves10.2174/138920008786485227
Artificial Membrane Assays to Assess Permeability
resolves10.1038/nchembio.293
The p110δ structure: mechanisms for selectivity and potency of new PI(3)K inhibitors
resolves10.1021/acs.jctc.5b00255
ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB
resolves10.1002/jcc.20035
Development and testing of a general amber force field
resolves10.4049/jimmunol.179.11.7891
Tissue- and Stimulus-Dependent Role of Phosphatidylinositol 3-Kinase Isoforms for Neutrophil Recruitment Induced by Chemoattractants In Vivo
resolves10.1182/blood-2009-07-232330
PI3K p110δ regulates T-cell cytokine production during primary and secondary immune responses in mice and humans
resolves10.1126/science.140.3565.405
Plaque Formation in Agar by Single Antibody-Producing Cells
The 1 reference without a DOI — listed, not checked
no DOI — not checkedAMBER 2015
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1021/acsmedchemlett.6b00119"><img src="https://citestamp.com/citestamped/10.1021/acsmedchemlett.6b00119/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1021/acsmedchemlett.6b00119/badge.svg)](https://citestamp.com/citestamped/10.1021/acsmedchemlett.6b00119)